Status:
COMPLETED
Study of Platelets Sialylation by Flow Cytometry for the Differential Diagnosis of ICT
Lead Sponsor:
Nantes University Hospital
Conditions:
Idiopathic Thrombocytopenic Purpura
Eligibility:
All Genders
18+ years
Brief Summary
Idiopathic thrombocytopenic purpura (ITP) is the most frequent auto-immune cytopenia. There is no specific biological marker and the diagnosis often results from the exclusion of other differential di...
Eligibility Criteria
Inclusion
- Adult patients (\>18yo) with a diagnosis of ITP (primary acute, persisting or chronical)
- Adult patients (\>18yo) with a diagnosis of non immunological thrombocytopenia (constitutive thrombocytopenia, myelodysplastic syndrome, chemotherapy-induced thrombocytopenia)
- Adult patients (\>18 yo) without thrombocytopenia
- Enrolled in a Social Security system
- Having provided informed consent
Exclusion
- Minor patients (\<18 yo)
- Enrolled in another clinical study
- Having received corticosteroids or polyvalent immunoglobulins in the past 4
- weeks or anti-platelet therapy or NSAID during the past 7 days
- Having received platelet transfusion in the past fortnight
- With proven iron deficiency
- With drug-induced immune-allergic thrombocytopenia.
- Pregnant and breastfeeding women,
- guardian patients, will be excluded from this population.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03421392
Start Date
January 1 2018
End Date
November 1 2020
Last Update
February 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nantes University Hospital
Nantes, France, 44093